Investigations on the effects of PSORS1C3, CARD14, and TLR4 polymorphisms are gradually increasing in the field of biomarker study in inflammatory diseases, such as psoriasis (Holm et al., 2005; Scudiero et al., 2011; Smith et al., 2016). The gene discussed is TLR4; the disease is psoriasis.